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ATG16L1, an autophagy mediator that specifies the site of LC3 lipidation, includes a C-
terminal domain formed by 7 WD40-type repeats (WD40 domain, WDD), the function of
which is unclear. Here we show that the WDD interacts with the intracellular domain of
cytokine receptors to regulate their signaling output in response to ligand stimulation. Using a
refined version of a previously described WDD-binding amino acid motif, here we show that
this element is present in the intracellular domain of cytokine receptors. Two of these
receptors, IL-10RB and IL-2Rγ, recognize the WDD through the motif and exhibit WDD-
dependent LC3 lipidation activity. IL-10 promotes IL-10RB/ATG16L1 interaction through the
WDD, and IL-10 signaling is suboptimal in cells lacking the WDD owing to delayed endo-
cytosis and inefficient early trafficking of IL10/IL-10R complexes. Our data reveal WDD-
dependent roles of ATG16L1 in the regulation of cytokine receptor trafficking and signaling,
and provide a WDD-binding motif that might be used to identify additional WDD activators.
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Macroautophagy (hereafter referred to as autophagy) is acatabolic pathway that degrades cytoplasmic compo-nents to maintain a healthy cellular homeostasis1,2. This
process is mediated by a group of proteins called autophagy-
related proteins (ATGs)3,4. Judging from the pathological phe-
notypes displayed by ATG-deficient mice, autophagy prevents a
number of diseases5,6, suggesting a possible value as a therapeutic
target7. However, different ATGs have been involved in activities
unrelated to the canonical autophagic pathway8–10. The con-
tribution of these atypical functions to the prevention of the
pathological phenotypes that arise in ATG-deficient conditions is
currently unclear. Therefore, identification and characterization
of such activities is important to establish exactly how the dif-
ferent ATGs prevent disease and how modulation of their activity
could be used as a valid therapeutic strategy.
ATG16L1, a critical autophagic effector that specifies the site of
LC3 lipidation11, is a particularly interesting example of this issue
because the canonical and unconventional functions of the mole-
cule appear to involve different domains. Thus, ATG16L1 includes
a C-terminal domain formed by 7 WD40-type repeats (WD40
domain, WDD)12 whose physiological functions have remained
unclear. This is because the N-terminal region of ATG16L1 binds
the LC3 lipidation machinery (the dimer ATG5-12)12,13 and suf-
fices to sustain canonical autophagy14–16, whereas the C-terminal
WDD (residues 320–607) is irrelevant for this basic route. Instead,
the WDD is critical for a collection of poorly characterized
unconventional activities where LC3 lipidation is activated in
single membrane, atypical subcellular localizations15–17, including
phagosomal vacuoles in a process called LC3-associated phago-
cytosis (LAP)16. The WDD is recognized by upstream activators
including a 4-aminoacid, tyrosine-based motif originally identified
in the transmembrane molecule TMEM59 ([YWF]-X3-[ED]-X4-
[YWF]-X2−L)15,17. Engagement of ATG16L1 through this motif
allows TMEM59 to label its own single-membrane endosomes
with LC3, thus increasing their fusion with the lysosomal com-
partment17. Therefore, the WDD appears to act as an interaction
module for proteins that enable the LC3 lipidation capacity of the
N-terminal domain in atypical subcellular localizations. We rea-
soned that the WDD-binding motif could help identify physiolo-
gical activators of the WDD and novel unconventional functions of
ATG16L1 carried out through this region. However, in its original
configuration the motif is too degenerated for productive com-
parisons with the protein sequence bank.
Here, we describe a strategy to improve the WDD-binding
signature using systematic mutagenesis and in vitro binding
studies based on peptide microarrays. This approach leads to a
refined motif version that facilitates the unbiased identification of
candidate WDD-interacting molecules. Notably, we find the
improved motif represented in the intracellular region of a
number of type-I transmembrane proteins, including different
cytokine receptors. We present data showing that one of the
receptors, IL-10RB, relies on the WDD for proper intracellular
trafficking and optimal signaling in response to IL-10.
Results
Refinement of the WDD-binding motif. We used peptide
microarrays to explore the impact of all possible aminoacids at all
positions of the active TMEM59 peptide (residues 268–280;
Fig. 1a) on the interaction with the WDD. Previous studies
indicate that this approach is feasible, since the 268–280 peptide
immobilized onto a glass slide is able to specifically bind WDD-
containing constructs15. Arrays including the unmodified ele-
ment, as well as a collection of mutant peptides where every
residue was changed to all possible aminoacids were probed with
a recombinant protein that includes the WDD (GST-HA-
ATG16L1231–607). Average binding data obtained for each mutant
were normalized against the binding value provided by the wild-
type peptide, and an arbitrary threshold was established to cate-
gorize as permissive or prohibited those substitutions with an
incomplete impact on the binding event (Fig. 1b; Supplementary
Fig. 1a, b). Data obtained for high and low ligand concentrations
were processed separately because some mutations qualified as
permissive or prohibited depending on the dose of the recom-
binant protein (see, for example, S271N; Fig. 1b). The resulting
heat-maps confirmed Y268, Y277, and L280 as the most restric-
tive positions, and revealed a new island of restriction around
aminoacid K273 (Fig. 1b). To establish how the distance between
critical residues may influence the interaction, we resorted to
arrays including peptides where such distances were altered by
introducing extra residues (alanine) or by deleting native ami-
noacids. However, changing the spacing between important
positions implicitly modifies the aminoacid composition of the
relevant stretch, and therefore there is an uncertainty as to
whether any impact in binding would originate from one or the
other varying parameters (distance vs. composition). We rea-
soned that, if a spacing-modified peptide fully retains the ability
to bind the ligand, the relevant distance should be considered as
permissive irrespective of whether or not less stringent mod-
ifications may inhibit the interaction. The results indicate that the
motif can accommodate substantial distance flexibility between
residues Y268-E272 and E272-Y277, whereas the distance
between Y277 and L280 cannot be modified without impairing
the interaction (Fig. 1c). Previous data showed that a negatively
charged residue (D or E) in position 272 is required for the LC3-
lipidation activity of TMEM59 but not for LC3-I recruitment17,
so to facilitate identification of a motif able to promote LC3
lipidation, the presence of D or E was imposed at this position.
Collectively, these studies led to a refined WDD-binding motif
version where most positions are defined by a discrete set of
allowed aminoacids (Fig. 1d).
Bioinformatic comparisons using the Prosite algorithm showed
that a wide variety of type-I transmembrane proteins include this
element in their intracellular region (Supplementary Data 1 and
2). Transmembrane proteins are particularly interesting in this
context, because their engagement of the WDD would facilitate
direct access of the ATG16L1-5-12 complex to a membrane
source for LC3 lipidation. Interestingly, the collection included 27
cytokine receptors (Supplementary Data 3 and 4), suggesting that,
similar to TMEM59, their intracellular trafficking and/or
functional features might be modulated by ATG16L1 through
the WDD15,17.
IL-2Rγ and IL-10RB include a functional WDD-binding motif.
To explore this idea, we implemented a sequential selection
approach directed to identify candidate receptors exhibiting
WDD-dependent mechanistic traits. We first tested a total of 12
receptors for binding to the WDD in co-precipitation studies. 11
of them were able to interact with the WDD (Fig. 2a; Supple-
mentary Fig. 2a), but only 5 did so specifically, without also
binding the N-terminal region of ATG16L1 (Fig. 2a). We focused
on these to evaluate their ability to induce LC3 lipidation. Pre-
vious studies indicate that overexpression of TMEM59 induces
unconventional, WDD-dependent LC3 lipidation15,17, so we used
this simple property to quickly identify those receptors whose
interaction with the WDD may result in activation of the LC3
lipidation complex. Transfection of IL-2Rγ, IL-10RB, and IL-
1RL1 (IL-33R) into HEK-293T cells caused robust lipidation of
co-transfected AU-LC3 (Supplementary Fig. 2b), whereas IL-
18R1 and IL-18RAP had a marginal activity (Supplementary
Fig. 2b). To examine if the autophagic activity of IL-2Rγ,
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IL-10RB, and IL-33R requires the WDD, we resorted to HCT116
cells expressing separated Nt (1–299) and Ct (300–607) domains
of ATG16L1. In these cells the effector Nt domain is physically
disconnected from the WDD interaction platform, thus impairing
LC3 lipidation in response to WDD engagement15. Notably,
while expression of IL-2Rγ, IL-10RB, and IL-33R triggered LC3
lipidation in cells harboring full-length ATG16L1, this activity
was blocked in cells expressing separated Nt and Ct domains
(Fig. 2b). This result points to a critical role of the WDD in the
LC3 lipidation activity triggered by these receptors. In addition,
we found significant colocalization between IL-2Rγ or IL-10RB
and co-transfected GFP-LC3, either in the absence (IL-2Rγ) or
presence (IL-10RB) of bafilomycin A1 to minimize receptor
degradation (Fig. 2c). This result indicates that at least part of the
lipidated LC3 that is generated by both receptors ends up dec-
orating their own intracellular vesicles. This is expected from an
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unconventional autophagic response induced by direct engage-
ment of ATG16L1 and the LC3-lipidation complex in the vicinity
of a membrane source for LC3 lipidation, as previously
described15,17. On the contrary, IL-33R showed poor colocaliza-
tion with GFP-LC3 that was not increased by bafilomycin A1
(Supplementary Fig. 2c), so this receptor was not further ana-
lyzed. The interaction of IL-2Rγ and IL-10RB with ATG16L1 was
solidified by additional co-immunoprecipitation studies per-
formed in different conditions (Supplementary Fig. 3a, b).
Importantly, mutational inactivation of the WDD-interaction
motifs present in IL-2Rγ and IL-10RB (Fig. 3a) impaired binding
of both receptors to the WDD (Fig. 3b) and full-length ATG16L1
(Supplementary Fig. 4a, b), as well as their ability to induce LC3
lipidation (Fig. 3c) and colocalization with GFP-ATG16L1 in co-
transfection experiments (Fig. 3d). These data indicate that both
IL-2Rγ and IL-10RB include functional motifs able to mediate
their interaction with ATG16L1 to induce LC3 lipidation. More
generally, these results show that the refined motif is able to
identify real interactors of the WDD. Although these rudimentary
overexpression assays were helpful to select candidate receptors
that exhibit WDD-dependent functional features, studying how
the biological activity of the selected molecules may be influenced
by the WDD requires the use of more sophisticated experimental
systems where candidate activity can be assessed in the presence
of the relevant co-receptors and in response to their natural
ligands.
Optimal IL-10 receptor signaling requires the WDD. To
explore how the interaction with ATG16L1 and the WDD may
shape the physiological properties of motif-containing cytokine
receptors, we focused on IL-10RB, the receptor of a prominent
anti-inflammatory cytokine (IL-10)18. Both ATG16L119 and the
WDD20 were previously shown to counter inflammation in dif-
ferent experimental paradigms, so we hypothesized that the
interaction between IL-10RB and ATG16L1 might be important
to sustain the anti-inflammatory function of IL-10. To develop a
suitable experimental system where we could unambiguously
assess the role of the WDD in IL-10R physiology, we restored
Atg16l1−/− mouse embryonic fibroblasts (MEFs) with different
versions of ATG16L1 and reconstituted the whole IL-10 signaling
system in these cells. Atg16l1−/− MEFs were first retrovirally
transduced with a STAT3-luciferase reporter system and a vector
expressing STAT3, the main transcription factor induced by IL-
1018. Cells were then restored with either full-length ATG16L1
(FL) or just the N-terminal domain (1–299; Nt), and subsequently
transduced with vectors expressing IL-10Rs A and B. Although
the Nt domain was expressed at slightly lower levels compared to
FL ATG16L1 (Supplementary Fig. 5a), the canonical autophagic
flux was recovered to a similar extent in both cell lines (Supple-
mentary Fig. 5b). Expression of both IL-10Rs was comparable
between cells harboring FL or Nt constructs (Supplementary
Fig. 5c). However, cells lacking ATG16L1 showed increased levels
of IL-10RA and B (Supplementary Fig. 5c), an unexpected effect
whose underlying mechanism is currently unknown. Surface
exposure of both IL-10Rs was also similar in FL and Nt cells
(Supplementary Fig. 5d, e), thus allowing direct comparison of
IL-10 activity between both cell lines to specifically evaluate the
role of the WDD. The engineered cells became responsive to IL-
10 (Supplementary Fig. 5f).
Co-immunoprecipitation studies revealed that IL-10 induces
the interaction between IL-10RB and FL-ATG16L1 (Supplemen-
tary Fig. 6a), an association that was strengthened by the
concomitant presence of lysosome inhibitors to prevent receptor
degradation (Supplementary Fig. 6b). No co-precipitation was
detected in cells expressing the Nt construct (Fig. 4a), indicating
that the WDD mediates this interaction. Surprisingly, immuno-
fluorescence assays showed a very low level of colocalization
between endocytosed IL-10RB and LC3 in IL-10-treated cells
(Supplementary Fig. 7a). However, pre-treatment with the
lysosomal inhibitor bafilomycin A1 revealed substantial IL-
10RB/LC3 colocalization in cells expressing FL ATG16L1
(Supplementary Fig 7b), likely because impairment of lysosomal
degradation slows down IL-10RB trafficking and facilitates
detection of transient LC3 decoration events that may be difficult
to observe. Interestingly, IL-10RB/LC3 colocalization was poorer
in cells expressing the Nt domain (Supplementary Fig. 7b),
arguing that IL-10R endosomes reach transient LC3-positive
compartments more efficiently through a mechanism involving
the WDD.
STAT3-dependent luciferase activity assays in response to IL-
10 showed that IL-10 signaling is defective in cells expressing the
Nt domain compared to those including FL ATG16L1 (Fig. 4b),
whereas the same activity induced by Leukemia Inhibitory Factor
(LIF) through endogenous receptors remains unaffected (Supple-
mentary Fig. 8a). The impaired IL-10 signaling output exhibited
by Nt cells was accompanied by reduced early cytoplasmic
phosphorylation of STAT3 (cytoplasmic extracts) and diminished
nuclear translocation of P-STAT3 (nuclear extracts), both in
response to continuous IL-10 treatment (Supplementary Fig. 8b)
and, more prominently, in pulse-chase experiments (Fig. 4c). The
latter approach also revealed reduced levels of IL-10 in
Fig. 1 WDD-binding motif refinement. aWDD-binding peptide present in TMEM59 intracellular domain (268–280). Critical motif positions are marked by
squares. b Peptide microarray studies to identify permissive aminoacids for WDD binding. Arrays containing the indicated peptide mutants were developed
with GST-HA-ATG16L1231–607 to obtain crude binding values. Heatmaps display binding data expressed as the average percentage of the wild-type binding
activity that is retained by each mutant. Left and right heatmaps show average data from assays performed at high (800, 600, 400 nM) and low (200, 50,
20 nM) ligand concentrations, respectively (3 experimental points, n= 8; statistics in Supplementary Fig. 1a). The color scale stretches continuously from
low (red) to high (blue) binding activity. The indicated threshold values were arbitrarily established as the average binding activity displayed by variants
that inhibit the interaction beyond 5%. Black/red figures indicate values above/below the threshold, thus establishing permissive/prohibited substitutions,
respectively. White squares indicate native aminoacids in the wild-type peptide. Permissive residues for all positions are displayed below the heatmaps.
c Microarray studies to establish the distance flexibility between critical residues. Microarrays including peptides with the indicated increased (left) or
decreased (right) distances between Y268-E272, E272-Y277, and Y277-L280 were developed as in a. 4 M indicates a control peptide where critical
residues are mutated to alanine (Y268A, E272A, Y277A, L280A). Shown are average binding activities processed as in a (−/+ s.d.). Data originate from 2
(left; 800, 400 nM (n= 6) except for E272-Y277 where n= 5) or 3 (right; 800, 600, 400 nM; n= 9) experimental points (n.s: P > 0,05; ***P < 0.001;
****P < 0.0001, two-sided Student’s t-test). Arrows indicate data defining the maximal (left) and minimal (right) distances allowed for each stretch. Thus,
peptides YVAPAASE (Y268-E272) and EKAALASAIY (E272-277) (left), or YE (Y268-E272) and ELY (E272-277) (right), fully retain WDD-binding activity,
indicating that 6 and 8 residues (left), or 0 and 1 (right), respectively, are permitted. Minimal variations in Y277-L280 spacing (YGADL; left) inhibit
binding, so the native 2-residue distance was considered critical and deletions were not tested. d Inclusive WDD-binding motif integrating permissive
residues and distance flexibility.
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cytoplasmic extracts of cells expressing the Nt construct (Fig. 4c),
pointing to a defect in endocytosis and/or trafficking of IL-10/IL-
10R complexes in the absence of the WDD.
Defective IL-10RB early trafficking in the absence of WDD. To
analyze the intracellular trafficking of IL-10Rs in response to
IL-10, we carried out immunofluorescence studies using an anti-
Flag antibody that recognizes Flag-tagged IL-10RB. Compared to
cells expressing FL ATG16L1, those harboring the Nt fragment
presented substantially reduced numbers of IL-10RB-Flag-
positive cytoplasmic vesicles early after IL-10 exposure (5 and
15 min time points; Fig. 4d). Similar results were obtained using
fluorescent dextran as an endocytic tracker (Supplementary
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Fig. 9a). The dissimilar numbers of Flag-positive vesicles in FL
and Nt cells were not normalized by blocking lysosomal function
with bafilomycin A1 (Supplementary Fig. 9b), suggesting that
they are not caused by a different degradation rate in the lyso-
somal compartment, but likely by reduced endosome formation
in Nt cells. These results point to the notion that absence of the
WDD impairs IL-10R endocytosis and/or endosome generation
in Nt cells.
To explore the endocytic route followed by IL-10/IL-10R
endosomes in both cell lines, we carried out immunofluorescence
colocalization studies between IL-10RB-Flag and early (EEA1)
and late (LAMP1 and Rab7) endocytic markers. Interestingly, the
degree of colocalization between endocytosed IL-10RB and EEA1
was reduced in cells expressing the Nt construct, not only 5 min
post-IL-10 exposure (where Nt cells show almost no IL-10RB
endosomes and therefore this parameter is probably irrelevant),
but also when comparing time points with similar numbers of IL-
10RB-positive endosomes (FL vs. Nt at 15 min of IL-10 treatment,
or FL at 5 min IL-10 vs. Nt at 15 min IL-10; Fig. 5a, b).
Comparable results were obtained in pulse-chase IL-10 experi-
ments (Supplementary Fig. 10a, b). However, the rate of
colocalization with the late endosomal/lysosomal markers
LAMP1 (continuous IL-10 treatment, Supplementary Fig. 11a,
b; pulse-chase, Supplementary Fig. 12a, b) and Rab7 (continuous
treatment, Supplementary Fig. 13a, b) remained comparable
between FL and Nt cells in those experimental points showing a
similar number of IL-10R-positive endosomes (FL vs. Nt at 15
min of IL-10 treatment, or FL 5 min vs. Nt 15 min). These results
are consistent with the notion that IL-10/IL10R complexes traffic
defectively to early endosomes in cells lacking the WDD, while
their eventual transit to late endosomes and/or lysosomes is not
substantially affected. Such comparable access to late compart-
ments suggests again that the degradation rate of IL-10/IL-10R
endosomes is unaltered by absence of the WDD, a result that is
consistent with the bafilomycin data mentioned above (see
Supplementary Fig. 9b). Together, these data point to the idea
that the WDD allows ATG16L1 to assist IL-10RB endocytosis
and trafficking to early endosomes upon activation by IL-10.
Defects in this mechanism caused by absence of the WDD result
in a reduced total number of endosomal vesicles carrying engaged
IL-10Rs, likely explaining the blunted IL-10 signaling output
exhibited by Nt cells.
An unconventional process where the autophagic machinery
favors receptor recycling from endosomal compartments to the
plasma membrane has recently been described (LC3-associated
endocytosis, LANDO)21. This phenomenon relies on the
autophagic protein Rubicon and, if mediated by the WDD, could
increase the steady state levels of IL-10Rs at the cell surface, thus
explaining the contribution of the WDD to IL-10R signaling.
However, depletion of endogenous Rubicon did not impair IL-10
signaling in MEFs expressing FL ATG16L1 (Supplementary
Fig. 14a), indicating that LANDO is unlikely to be the primary
mechanism through which the WDD regulates IL-10R physiol-
ogy. MEFs expressing FL ATG16L1, IL-10RA and a mutated
version of IL-10RB that is unable to bind the WDD (5M) showed
impaired STAT3-dependent luciferase activity induced by IL-10,
and the magnitude of such defect was comparable to that
observed in cells expressing the Nt domain (Supplementary
Fig. 14b). This result argues that the defective signaling output
caused by absence of the WDD is likely due to impairment of the
IL-10RB/ATG16L1 interaction, not to indirect effects.
Defective IL-10 signaling in macrophages lacking the WDD. To
recapitulate these results in a cellular system naturally responsive
to IL-10, we resorted to the human monocytic cell line THP1,
which acquires macrophage traits upon PMA treatment22,23.
Endogenous expression of ATG16L1 was reduced in these cells
using the CRISPR/Cas9 system directed to a target sequence that
encodes for aminoacids included in the WDD (342–348).
Expression of the Nt domain of ATG16L1 (aminoacids 1–299) in
this cellular strain yielded expression levels comparable to those
of the endogenous molecule (Supplementary Fig. 15a), thus
allowing to test the function of the WDD in a system where the
relative expression of ATG16L1 (endogenous) and the Nt domain
(ectopic) is not as dissimilar as in MEFs. Both cell lines exhibited
equivalent levels of basal autophagy (Supplementary Fig. 15b).
Again, we observed enhanced IL-10R expression in cells lacking
ATG16L1 (Supplementary Fig. 15c), but their protein levels
(Supplementary Fig. 15c) and surface exposure (Supplementary
Fig. 15d) were comparable in cells expressing FL or Nt ATG16L1.
Treatment with IL-10 showed reduced ability in the latter strain
to cause translocation of P-STAT3 to the nucleus (Fig. 6a), and to
suppress the induction of inflammatory mediators in response to
LPS treatment (Fig. 6b). Therefore, IL-10 signaling is also dis-
rupted by the absence of the WDD when it is induced by
endogenous IL-10Rs. In addition, such defect is also observed
when the expression levels of FL-ATG16L1 and Nt are compar-
able, thus solidifying the results obtained in reconstituted MEFs.
Mice expressing a truncated form of ATG16L1 that lacks the
WDD (E230) overcome the perinatal lethality exhibited by whole-
organism ATG-deficient animals24, and therefore can be used to
study the functions of the WDD in adult tissues. Bone marrow-
derived macrophages (BMDMs) from these mice differentiated
normally as established by the expression levels of CD11b and F4/
80 surface markers (Supplementary Fig. 16a), and expressed the
expected 25 kDa fragment of ATG16L1 corresponding to
aminoacids 1–230 (Supplementary Fig. 16b). Consistent with
Fig. 2 Selection of candidate receptors showing WDD-dependent functional features. a Co-immunoprecipitation studies to identify receptors able to
specifically interact with the WDD. HEK-293T cells were co-transfected with tagged forms of the indicated cytokine receptors along with constructs
including the WDD (320–607) or ΔWDD (1–319) fused to GST, as shown. Cells were lysed 36 h later and subjected to GST immunoprecipitation with
agarose beads coupled to GSH. Shown are Western-blots against the indicated molecules. IP: immunoprecipitate; TL: total lysate. b Evaluation of WDD-
dependent LC3 lipidation activity. ATG16L1−/− HCT116 cells restored with the indicated versions of ATG16L1 (full-length (FL) or separated N-terminal (Nt;
1–299) and C-terminal (Ct; 300–607) domains) were transfected with the shown tagged cytokine receptors along with plasmids expressing AU-LC3 and
GFP. Cells were lysed 36 h post-transfection for Western-blotting against the indicated molecules. The expression levels of co-transfected GFP remain
unchanged, indicating equal transfection efficiency. c Colocalization between transfected cytokine receptors and co-expressed GFP-LC3. HeLa cells were
transfected with the indicated tagged cytokine receptors and a plasmid expressing GFP-LC3. Cells were treated with bafilomycin A1 (75 nM, as indicated)
during the last 6 h of culture, fixed 36 h post-transfection, stained with an anti-Flag antibody and scored for colocalization between the Flag signal (red) and
GFP-LC3. Shown are representative confocal pictures (left) where the white arrows indicate colocalization events. Graphs (right) display the percentage of
Flag-positive vesicles colocalizing with the GFP-positive signal in the different conditions −/+ s.d. (n= 23 cells for IL-10RB; n= 25 cells for IL-2Rγ; n.s: P >
0,05; ***P < 0.001, two-sided Student’s t-test).
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the results described above, we found reduced ability of IL-10 to
promote nuclear translocation of P-STAT3 in E230 macrophages
(Fig. 6c; Supplementary Fig. 16c). This defect correlated with
impaired induction of Bcl3 (Fig. 6d), a direct target of IL-10 that
mediates the anti-inflammatory response25, and also with
diminished suppression of TNF mRNA induction by LPS
(Fig. 6e).
Discussion
Our results show that the WDD is required for optimal IL-10
signaling by allowing ATG16L1 to interact with IL-10RB, thus
favouring endocytosis and early trafficking of IL-10/IL-10R
complexes. The WDD does not appear to influence the nature of
the endocytic route followed by the activated IL-10Rs, nor it
seems to control their degradation rate in the lysosomal
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compartment. Instead, by favouring IL-10R endosome formation
without influencing their degradation, it increases the total
number of endosomes carrying activated IL-10Rs that navigate
through the cytoplasm upon IL-10 stimulation. Since endosomes
are recognized as an important signaling platform26, we believe
that such increased number of signaling-competent endosomes
likely explains the enhanced IL-10R output that we observe in
cells expressing FL ATG16L1 compared to those harboring the Nt
region. However, we cannot completely exclude that the WDD
may also facilitate access of IL-10R endosomes to an unknown
sub-compartment that enables optimal signaling.
Exactly how the WDD and ATG16L1 promote endocytosis of
IL-10Rs is currently unclear. A previously described interaction
between the N-terminal region of ATG16L1 and the clathrin-
heavy chain27 might help increase the rate of endocytosis upon
recruitment of ATG16L1 to the activated IL-10Rs, although a
possible role of LC3 lipidation in this scenario would not be
obvious. In this context ATG16L1 might function mainly as a
scaffold protein, independently of its LC3 lipidation capabilities.
How ATG16L1 promotes efficient trafficking of IL-10R to early
endosomes is also unclear at this stage. Although LC3 has his-
torically been linked to a degradative outcome in a variety of
pathways, ranging from canonical autophagy4 to LAP28, it is also
known to promote membrane fusion events29, for example those
involved in the secretion of lysosomal contents through the
osteoclast ruffled border30. A role of LC3 in membrane fusion
could facilitate the transition of newly formed, LC3-labeled IL-
10R endosomes to EEA1-positive early compartments, a scenario
that would point to a non-degradative function of LC3 in IL-10R
physiology. Such unconventional function of LC3 may be implicit
in this case, since its canonical degradative role would be expected
to increase fusion of LC3-labeled IL-10R endosomes with the
lysosomal compartment to cause earlier signal cessation, instead
of an enhanced output. More generally, our data reinforce the
notion that timely endocytosis and efficient early intracellular
trafficking of activated IL-Rs are required factors for optimal
signaling.
We believe that a similar mechanism is likely to regulate the
function of other cytokine receptors that may include a functional
WDD-binding motif in their intracellular region. Interestingly,
we found that some of the IL-Rs that interact with the WDD also
appear to bind ATG16L1 through the Nt domain, thus adding an
additional layer of complexity to the IL-R/ATG16L1 functional
crosstalk. The nature of such interaction with the Nt domain is
currently unclear, although, as mentioned above, it could be
facilitated by the clathrin-heavy chain27. Using the refined WDD-
binding motif version we have identified a wider collection of
functionally unrelated type-I transmembrane proteins that
include this element in their intracellular domain, including a
variety of adhesion proteins, innate immune receptors and other
uncharacterized molecules. Since their binding to the WDD is
likely to depend on issues like molecular context and con-
formational accessibility of their different motifs, we do not
expect that all of them will interact with the WDD and ATG16L1
in a natural setting. Establishing how many of them are actually
able to interact with the WDD and the functional consequences
of such interaction will require additional studies.
Different roles of autophagy in the control of the endocytic
route have previously been described. LANDO involves labeling
of internalized endosomes with LC3 to promote recycling of
endocytosed receptors back to the plasma membrane instead of
their lysosomal degradation, thus making them available again for
ligand stimulation21. However, we show that depletion of Rubi-
con, an essential mediator of LANDO, does not impair IL-10
signaling, indicating that the WDD probably confers optimal IL-
10R performance through a different mechanism. In addition,
defective autophagy has been shown to induce endosome damage,
EGFR accumulation in EEA1-postive vesicles and compromised
signaling31. Absence of the WDD is unlikely to provoke a similar
phenomenon, since we found reduced levels of IL-10RB coloca-
lizing with EEA1, rather than IL-10RB accumulation in this
compartment. These considerations argue that we have dis-
covered a new molecular mechanism mediated by the WDD to
regulate cytokine receptor trafficking and signaling.
A coding polymorphic allele of ATG16L1 (rs2241880; T300A)
increases the risk of Crohn disease32–35, and impairs binding
between the WDD and certain proteins including the WDD-
binding motif15, so the mechanism that we describe here might be
dysregulated by ATG16L1-T300A to facilitate disease onset.
Although it is difficult to anticipate how immune responses might
be globally influenced by a mechanism that could regulate the
function of several cytokine receptors at once, the role of the
WDD in IL-10 signaling might explain some of the pro-
inflammatory phenotypes exhibited by ATG16L1-deficient
experimental systems19,36. We provide a collection of candidate
receptors whose detailed and comprehensive analysis could reveal
a wider role of the WDD in immune regulation and/or inter-
cellular communication under a variety of physiological and
pathological conditions. More generally, our improved WDD-
binding motif may help identify additional molecules and
mechanisms regulated by the unconventional engagement of
ATG16L1 through the WDD.
Methods
Peptide microarray studies. Peptide microarrays were ordered from JPT
(Germany) and included each peptide printed by triplicate in three different sub-
arrays (9 spots per peptide in each microarray). Peptides were immobilized
through the N-terminal end using a long spacer (Tds). To purify the recombinant
ligand, we transduced HEK-293T cells with a retroviral construct expressing
Fig. 3 Motif-dependent activities of IL-10RB and IL-2Rγ. a Motif-containing peptides in IL-10RB and IL-2Rγ. Critical residues highlighted in red font were
mutated to alanine in order to explore motif-dependent functions. IL-2Rγ Y303 is not strictly part of the motif, but it was also mutated since Y favors
binding to the WDD at all positions of the peptide. b Co-precipitation studies between wild-type or motif-mutated versions of the receptors and GST-
WDD. HEK-293T cells were co-transfected with Flag-tagged wild-type (WT) or motif-mutated (5M or 6M) forms of the indicated tagged cytokine
receptors and a construct expressing GST-WDD (320–607). Cells were lysed 36 h later and subjected to GST immunoprecipitation with agarose beads
coupled to GSH. Shown are Western-blots against the indicated molecules. IP: immunoprecipitate; TL: total lysate. c Evaluation of motif-dependent LC3
lipidation activity. HEK-293T cells were transfected with the indicated versions of HA-tagged IL-10RB and IL-2Rγ (WT or 5M) along with a plasmid
expressing AU-LC3. Cells were lysed 36 h post-transfection for Western-blotting against the indicated molecules. d Evaluation of motif-dependent co-
localization between the cytokine receptors and GFP-ATG16L1. HeLa cells were transfected with the indicated versions of Flag-tagged IL-10RB and IL-2Rγ
(WT or 5M) and a plasmid expressing GFP-ATG16L1. Cells were fixed 36 h post-transfection, stained with an anti-Flag antibody and scored for
colocalization between the Flag (red) signal and GFP-ATG16L1. Shown are representative confocal pictures (left, where the white arrows indicate
colocalization events), and graphs (right) representing the percentage of Flag-positive vesicles colocalizing with the GFP-positive signal −/+ s.d. (left axis,
white bars, solid dots) together with the total number of Flag-positive vesicles per cell −/+ s.d. (right axis, gray bars, white dots); n= 20 cells for IL-10RB
and n= 23 cells for IL-2Rγ; n.s: P > 0,05; **P < 0.01; ****P < 0.0001, two-sided Student’s t-test.
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GST-HA-ATG16L1-230-607 followed by an IRES-puromycin element for selection
(1 μg/ml). Cells were lysed in 1% Igepal CA-630 lysis buffer. The resulting clarified
lysates were diluted to a final detergent concentration of 0,2% and incubated with
GSH-Agarose beads for 4 h/4 °C. The recombinant protein was eluted from the
matrix using 50 mM reduced GSH, and concentrated by centrifugation using a
YM-30 Centricon filtering device (Amicon). The approximate final yield was
1–2 μg per 10-cm plate (around 107 cells). Samples were run in protein gels and
stained with Coomasie Blue to evaluate integrity and approximate protein quantity.
A more accurate protein quantification was obtained using the DC Protein Assay kit
(BioRad). Microarray slides were first blocked in a solution containing PBS/0,05%
Tween-20 (PBS-T) supplemented with 5% BSA for 2 h at RT, and washed in PBS-T
with gentle shaking. Ligand incubation was done in blocking solution containing the
desired concentration of the recombinant protein for 2 h at RT plus overnight at
4 °C. After additional washes in PBS-T, the slides were incubated with a mixture of
anti-HA (mouse monoclonal; Covance (16B12, mouse, Babco BioLegend 901501))
and anti-GST (rabbit polyclonal; Cell Signaling (rabbit, Cell Signaling 2622)) anti-
bodies (10μg/ml each in blocking buffer) for 2 h at RT. Arrays were then developed
with a solution containing a mixture of Cy5-labeled goat anti-mouse and rabbit
(Jackson Immunoresearch) antibodies (1:1000 dilution in blocking buffer, 1 h at RT)
followed by repeated washing in PBS-T. A final wash with MilliQ distilled water
allowed removal of salt residues. Slides were scanned using a GenePix 4000B
scanner (Molecular Devices) and the resulting images analyzed using the GenePix
Pro 6.0 software. Data were analyzed using Microsoft Excel 1902.
Prosite comparisons. The WDD-binding motif resulting from peptide microarray
binding studies was used to scan the landscape of human type-I transmembrane
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proteins using the Option 2 (Submit MOTIFS to scan them against a PROTEIN
sequence database) of the ScanProsite Tool of the ExPASy Bioinformatics Resource
Portal (https://prosite.expasy.org/scanprosite/). We first generated a Fasta file
including all type-I transmembrane proteins present in the human genome as
annotated in the Uniprot sequence database. The database was downloaded from
the Uniprot website (https://www.uniprot.org) after using the search term: loca-
tions:(location:“Single-pass type I membrane protein [SL-9905]”) AND reviewed:
yes AND organism:“Homo sapiens (Human) [9606]”. The resulting list included
1228 proteins (in year 2017) and is provided as Supplementary Data 5. We then
instructed the ScanProsite server to find in this file proteins containing the refined
motif in their primary sequence. To account for motif versions including spacing
distances between critical residues that are shorter than those natively present in
TMEM59, we performed repeated comparisons with motif versions progressively
lacking all possible combinations of the aminoacids previously identified as allowed
for each position, as determined by the microarray binding assays. The resulting
collection of identified molecules was consolidated to eliminate redundant hits,
filtrated to identify those including the motif in their intracellular domain and
further processed to exclude kinases and phosphatases, since the motif tended to be
represented in the active center of such functional domains. The final, curated
collection of candidates included 304 type-I transmembrane proteins presenting
the motif in the intracellular region.
Cell lines and reagents. HEK-293T, HeLa, and THP1 cells were obtained from the
American Type Culture Collection. The ATG16L1−/− HCT116 cell line was
obtained from Dr. David Boone (Indiana University School of Medicine, South
Bend, Indiana, USA)37, and Atg16L1−/− MEFs were kindly shared by Dr. Ramnik
Xavier (Broad Institute MIT and Harvard, USA)38. ATG16L1−/− HCT116 cells
restored with FL-ATG16L1 or separate Nt (1–299) and Ct (300–607) domains of
ATG16L1 were generated by retroviral transduction of the relevant DNA con-
structs15. Atg16L1−/− MEFs were engineered to study IL-10 signaling by trans-
ducing them first with a retroviral STAT3-luciferase reporter system and a plasmid
expressing human STAT3. Cells were then restored with retroviral constructs
expressing FL-ATG16L1 or the N-terminal region (residues 1–299). Finally, cells
were transduced with a mixture of retroviral supernatants harboring human IL-
10RA-AU and IL-10RB-Flag. An additional strain expressing ectopic AU-LC3B
(human) via retroviral transduction was generated to study the colocalization
between endocytosed IL-10RB and LC3 in response to IL-10 treatment. THP1 cells
were infected with lentiviruses expressing CRISPR/Cas9 guides directed to posi-
tions 78–97 or 1025–1044 of the ATG16L1 mRNA (counting from the first coding
nucleotide in ATG16L1 mRNA); see below Transfections and retroviral/lentiviral
transductions for further details. The latter were then restored via retroviral
transduction of a construct expressing the Nt domain of ATG16L1 (1–299) or an
irrelevant vector as a control. Cells were cultured at 37 °C and a humidified 5%
CO2 atmosphere, in DMEM (Invitrogen) containing 10% heat-inactivated FBS
(Invitrogen), 2 mM glutamine and 100 U/ml of penicillin/streptomycin (Invitro-
gen). Bafilomycin, pepstatin and rapamycin were purchased from Sigma, and E64d
from Calbiochem. Recombinant human and mouse IL-10, LIF, and M-CSF were
obtained from Life Technologies, R&D, Peprotech and BioLegend, respectively. For
pulse-chase experiments in response to IL-10, cells were incubated with the
cytokine for 30 min on ice, washed twice and incubated at 37 °C for the relevant
times before lysis for Western-blotting or fixation for immunofluorescence.
DNA constructs. All constructs were cloned into the pEAK series of mammalian
expression vectors or a retroviral derivative called P12-MMP. DNA constructs
expressing HA-tagged and GST-tagged human ATG16L1, ΔWDD (1–319) and
(1–299), WDD (320–607) and (300–607), AU-LC3, GFP-LC3, GFP-ATG16L1 have
been generated by PCR and fully verified by sequencing15,17. Human full-length
cDNAs for IL-2Rγ (BC014972), IL-10RB (BC001903), IL-4RA (BC136365), IL-6RB
(BC117402), IL-12RB2 (BC104772), IL-20RA (BC113574), IL-21R (BC004348) and
IL-31RA (BC110490) were obtained from the Mammalian Gene Collection (MGC,
Dharmacon, GE Healthcare). The cDNAs for IL-18R1 and IL-18RAP were pur-
chased from Origene (refs. SC117718 and SC117717, respectively). The IL-17RD
cDNA was an incomplete clone purchased from GE healthcare (BC111702; MGC,
Dharmacon) where the first native aminoacid is G43 (as in RefSeq NM_017563),
thus lacking the N-terminal signal peptide. To allow expression of the clone, the
cDNA was fused in-frame to a heterologous leader cassette from the human CD5
protein that leaves an in-frame HA tag at the N-terminus upon cleavage of the
leader sequence (CD5L-HA). The cDNA for IL-33R (IL-1RL1; ST2) was kindly
shared with us by Dr. Ken Yanagisawa (Jichi Medical School, Tochigi, Japan). The
different interleukin receptors were C-terminally tagged with GST, HA or Flag by
PCR and verified by sequencing. The sequences of the relevant oligos are shown in
Supplementary Table 1. Mutants in critical positions of the WDD-binding motif
were introduced by site-directed mutagenesis and verified by sequencing (oligo-
nucleotide sequences shown in Supplementary Table 2). The IL-18R1 cDNA
contained a 57 base pair insertion compared with the RefSeq clone NM_003855,
likely representing an unremoved intron. This anomalous sequence introduced a
premature stop codon that resulted in a truncated protein, and was removed by
site-directed mutagenesis (oligonucleotide sequences shown in Supplementary
Table 2). The STAT3 cDNA was obtained from Addgene (pLEGFP-WT-STAT3;
ref. 71450) and swapped into the P12-MMP retroviral vector. Tagged constructs
were generated by PCR and fully verified by sequencing. To reconstitute the IL-10
signaling system in MEFs, the IL-10RB-Flag cDNA was cloned upstream of an
IRES-GFP cassette to verify equal transduction efficiency. The IL-10RA cDNA
(GE-Dharmacon; BC028082) was C-terminally tagged with AU1 and also cloned
into P12-MMP. The retroviral STAT3-luciferase reporter vector was derived from a
NF-κB-luciferase retroviral construct originally obtained from Dr. Felix Randow
(LMB, Cambridge, UK). The NF-κB enhancer was excised using HpaI/XhoI and an
oligonucleotide including 4× STAT3 binding sites was inserted 3 times using the
same restriction sites (oligonucleotide sequence shown in Supplementary Table 3).
Transfections and retroviral/lentiviral transductions. Transfections were done
using the jetPEI lipid reagent (Polyplus) following the instructions provided by the
manufacturer. Retroviral transductions were performed to express transgenes
cloned into the P12-MMP retroviral vector. Virus-containing supernatants were
generated by co-transfecting HEK-293T cells with the relevant P12-MMP con-
structs together with helper plasmids expressing gag-pol (pMD.gag-pol) and env
(VSV-G; pMD-G). Infections were carried out by diluting the viral supernatants
with fresh medium (1:1) in the presence of polybrene (8 µg/ml), and spinning the
resulting mix onto the target cells for 1 h at 2000 rpm, 32 °C. To deplete ATG16L1
in THP1 cells or Rubicon in MEFs using the CRISPR/Cas9 system, we relied on the
lentiCRISPRv2 vector (Addgene, refs. 52961 or 98293). RNA guides were selected
using the BreakingCas server at the Centro Nacional de Biotecnología (Madrid,
Spain; https://bioinfogp.cnb.csic.es/tools/breakingcas/index.php; oligonucleotide
sequences shown in Supplementary Table 4), cloned into this vector using BsmB1
restriction sites and the resulting constructs co-transfected with the helper plasmids
psPAX2 (Addgene ref. 12260) and pCMV-VSV-G (Addgene, ref. 8454) into HEK-
293T cells. Viral supernatants were collected, filtered and diluted 4:1 with fresh
medium. Infections were carried out by spinning the resulting mixture (1 h, 2000
rpm, 32 °C) onto the target cells in the presence of polybrene (8 µg/ml). Cells were
selected in puromycin (1 μg/ml) or blasticidin (2 μg/ml) for a week and lysed to
evaluate protein expression. The resulting polyclonal population exhibited exten-
sive protein depletion (beyond 95%) and was used as such for further studies.
Fig. 4 Function of the WDD in IL-10R signaling examined in engineered MEFs. Cells in all panels are Atg16L1−/− MEFs engineered to harbor a STAT3-
luciferase reporter system and to express STAT3, subsequently restored with full-length ATG16L1 (FL) or a deleted version lacking the WDD (Nt, 1–299),
and retrovirally transduced to express IL-10Rs A and B. a Co-precipitation between IL-10RB and ATG16L1 as a function of IL-10 treatment. The indicated
cells (FL or Nt) were treated with IL-10 and E64d/pepstatin (10 μg/ml each) for 30min or left untreated. Cells were then lysed and processed for anti-Flag
immunoprecipitation. Shown are Western-blots against the indicated molecules. IP: immunoprecipitate; TL: total lysate. b Time-course and dose-response
activation of STAT3-luciferase activity by IL-10. The indicated cells (FL or Nt) were treated with IL-10 for the shown times (100 ng/ml; top panel) or with
the indicated doses of IL-10 (4 h; bottom panel), and lysed to measure luciferase activity. Data are expressed as the mean of fold induction of luciferase
activity −/+ s.d of triplicate experimental points (n= 3; **P < 0.01; ***P < 0.001; ****P < 0.0001, two-sided Student’s t-test) from a representative
experiment. c Pulse-chase assay of IL-10-induced STAT3 phosphorylation. Cells (F: FL, N: Nt) were pre-incubated with IL-10 (50 ng/ml; 30min on ice),
incubated at 37 °C for the shown times and lysed to obtain cytoplasmic and nuclear extracts for Western-blotting against the indicated molecules (H3,
Histone-3). Corrected densitometric quantifications are shown at the bottom of the Western-blot images. d Immunofluorescence assay to evaluate the
number of Flag-positive intracellular vesicles in IL-10 treated cells. The indicated cells were incubated with IL-10 (50 ng/ml) for the shown times and
processed for anti-Flag immunofluorescence. Shown are representative confocal pictures (left). The graph (right) displays the number of Flag-positive
vesicles per cell in the different conditions. Data are presented as box-plots where the central line represents the median value, the box shows percentiles
25–75 and the whiskers include the most extreme values (n= 56, n= 68 cells for untreated and treated samples, respectively; *P < 0.05; ****P < 0.0001,
two-sided Student’s t-test).
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Western blotting and co-precipitation studies. To obtain total lysates for
polyacrylamide gel electrophoresis and Western-blotting, cells were collected by
centrifugation and resuspended in 2× SDS sample buffer (SB) lacking β-
mercaptoethanol and bromophenol blue (100 mM Tris-HCl pH 6.8, 4% SDS, and
20% glycerol) supplemented with PMSF (10 μg/ml, Roche) and a Protease Inhibitor
Cocktail (PIC, Sigma). After vigorous vortexing, samples were boiled for 15 min
and then spun for 5 min at top speed to remove cellular debris. To generate
cytoplasmic and nuclear extracts, cells were lysed on ice for 30 min in a buffer
containing 1% Igepal CA-630 detergent (Sigma), 150 mM NaCl, 50 mM Tris pH
7.5, 5 mM EDTA, protease inhibitors (PMSF and PIC) and phosphatase inhibitors
(β-glycerophosphate (25 mM, Sigma); sodium fluoride (5 mM, Sigma) and ortho-
vanadate (1 mM, New England Biolabs)). After a 10 min centrifugation step, the
supernatant was collected as a cytoplasmic lysate. To obtain the corresponding
nuclear extracts, the remaining pellet was lysed in SB as described above. Protein
concentrations were measured using the DC Protein Assay (BioRad). For co-
immunoprecipitation studies, cells were lysed in the same 1% Igepal CA-630 buffer
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described above and the resulting cytoplasmic lysates diluted 1:5 in the same buffer
lacking detergent to a final detergent concentration of 0,2% to preserve protein
interactions. Lysates were pre-cleared with agarose beads (1 h, 4 °C, rotation) and
then subjected to immunoprecipitation with the relevant antibodies (2–3 h, 4 °C,
rotation) plus agarose beads coupled to protein G (1 h, 4 °C, rotation), or agarose
beads coupled to GSH (2–3 h, 4 °C, rotation). Immunoprecipitating antibodies:
Anti-Flag (1/150, D6W5B, rabbit mAb, Cell Signaling 2368), anti-IL-10RB (1/50,
F6, mouse mAb, Santa Cruz sc-271969), anti-ATG16L1 (1/100, rabbit polyclonal,
MBL PM-040), irrelevant rabbit immunoglobulin (Merck, Millipore). Beads
were washed 3–4 times with ice-cold immunoprecipitation buffer (0,2%
detergent), resuspended in 2× Reducing Sample buffer (SB, supplemented with
β-mercaptoethanol (10%) and bromophenol blue (0,2%)), and boiled for 10 min.
Equal amounts of protein or immunoprecipitated eluates were resolved by SDS-
PAGE, transferred to a polyvinilidene difluoride membrane (Millipore) to be
probed with the relevant primary antibodies: anti-GST (1/1000, rabbit polyclonal,
Cell Signaling 2622), anti-HA (1/1000, 16B12, mouse mAb, Babco BioLegend
901501), anti-AU1 (1/1000, rabbit polyclonal, Thermo PA1-26548), anti-Flag (1/
1000, M2, mouse mAb, Sigma F3165), anti-GFP (1/5000, B34, mouse mAb, Bio-
Legend 902601), anti-ATG16L1 (1/2000, 1F12, mouse mAb, MBL M150-3), anti-
IL-10RA (1/500, A3, mouse mAb, Santa Cruz sc-365374), anti-IL-10RB (1/500, F6,
mouse mAb, Santa Cruz sc-271969), anti-phospho-STAT3-Y705 (1/1000, rabbit
polyclonal, Cell Signaling 9131), anti-STAT3 (1/1000, mouse mAb, Cell Signaling
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9139), anti-IL-10 (1/1000, D13A11, rabbit mAb, Cell Signaling 12163), anti-
Histone-3 (1/1000, D1H2, rabbit mAb, Cell Signaling 4499), anti-LC3 (1/1000,
mouse mAb, MBL M186-3), anti-p62 (THPs, 1/1000, mouse mAb, BD 610833;
MEFs 1/1000, rabbit polyclonal, MBL PM045), anti-Rubicon (1/1000, D9F7, rabbit
mAb, Cell Signaling 8465), anti-GAPDH (1/10000, 6C5, mouse mAb, Abcam
ab8245). After incubation with the appropriate secondary HRP- (Jackson Immu-
noresearch) or DyLight- (ThermoFisher) coupled antibodies (1/10000), blots were
developed by chemiluminescence using the ECL (Amersham) or Odissey infrared
imaging systems, respectively. Signal quantifications were carried out with the
ImageJ software. Crude densitometric values for P-STAT3 or IL-10 were corrected
by the values provided by control Western-blot signals (total STAT3, GAPDH or
Histone-3, H3).
Flow cytometry. Cells were detached using the trypsin-free Accutase Solution
(Sigma), resuspended in culture medium containing 0,1% azide and a 1:100 dilu-
tion of mouse or rat immunoglobulins (Sigma) as blocking agents, and incubated
for 30 min on ice. The specific antibodies were then added to the cell suspension at
a 1:100 dilution, and an additional incubation was carried out on ice for 30 min.
Cells were then washed repeatedly. All specific antibodies were purchased from BD:
anti-mouse-CD11b-BB515 (rat, BD 564454), anti-mouse-F4/80-Alexa Fluor 647
(rat, BD 565853), anti-human-IL-10RA-Alexa Fluor 647 (rat, BD565255), anti-
human-IL-10RB-Alexa Fluor 647 (mouse, BD 564372). Control antibodies were:
mouse IgG1-Alexa Fluor 647 (BD 557714) and rat IgG2b-BB515 (BD 564421).
Cells were analyzed in an Accuri C6 (BD BioSciences) cytometer running on
version 1.0.264.21 of the Accuri C6 software. Details on the gating and quantifi-
cation strategies are provided in the figure legends and Supplementary Fig. 17.
Immunofluorescence and confocal microscopy. Cells were seeded onto poly-L-
lysine coated coverslips, transfected or treated the next day and, in most cases, fixed
in 4% paraformaldehyde (RT, 15 min). Preparations were permeabilized in a PBS/
0,5% Igepal/100 mM glycine solution (RT, 30 min), blocked in PBS/3% BSA (RT,
45 min) and stained with primary and secondary antibodies (RT, 1 h) diluted in
PBS/2%BSA. Samples generated to detect LC3 with an anti-LC3 antibody were
fixed with methanol (100%, −20 °C, 5 min) and further processed as described
above. Primary antibodies were: anti-Flag (in most cases rabbit polyclonal (1/2000,
Cell Signaling 2368); mouse monoclonal (1/100, Sigma F3165) for co-staining with
anti-EEA1), anti-EEA1 (1/750, EPR4245, rabbit mAb, Abcam ab109110), anti-LC3
(1/200, 5F10, mouse mAb, NanoTools 0231-100), anti-LAMP1 (1/200, EPR21026,
rabbit mAb, Abcam, ab208943), anti-Rab7 (1/100, EPR7589, rabbit mAb, Abcam,
ab137029). Secondary antibodies were AffiniPure goat anti-mouse or anti-rabbit-
Cy3 and goat anti-mouse or anti-rabbit Cy5 (Jackson Immunoresearch, 1/400).
Studies with Dextran as an endocytic tracker (Dextran-Alexa Fluor 647, 10.000
MW fixable, Invitrogen, D22914) were done by co-incubating the relevant cell lines
with IL-10 (40 ng/ml) and dextran (100 μg/ml) for the required times and then
processing them following the same protocol used for conventional immuno-
fluorescence, avoiding the detergent permeabilization step. Analysis of surface IL-
10R expression by immunofluorescence was done by incubating the adhered cells
with the same primary antibodies and under the same conditions as for flow
cytometry (see above), and subsequently fixing them in 4% paraformaldehyde as
for immunofluorescence. Samples were analyzed in a Leica SP5 confocal micro-
scope. Except for surface IL-10Rs, images obtained for Cy5 were pseudocoloured in
green for more clarity. Scale bars represent 10 μm in all micrographs. Colocaliza-
tions were evaluated in transfected HeLa cells by blindly scoring the percentage of
receptor-positive vesicles (stained with anti-Flag and Cy3) that show a clearly
overlapping signal with GFP (GFP-LC3 or GFP-ATG16L1) in the confocal pic-
tures. Colocalization between endocytosed IL-10R and EEA1, LAMP1, Rab7, or
LC3 was evaluated using the Colocalization Statistics software of the LAS AF X
Core Suite, version 2.7.3.9723 (Leica Microsystems). The number of IL-10RB-
positive vesicles per cell was established by blindly counting the labeled vacuoles on
confocal images.
Luciferase assays. Engineered MEFs were plated in complete medium, pre-
incubated the next day for 4 h in medium containing 0,5% FCS, treated with the
cytokine in the same low serum medium and lysed for luciferase activity using the
Luciferase Assay System (Promega), essentially following the instructions provided
by the manufacturer.
Assays with THP1 cells and BMDMs. THP1 cells were pre-treated with PMA
(125 ng/ml) for 48 h in complete medium (10% FCS) to promote their differ-
entiation to a macrophage-like phenotype. Cells were then incubated in 1% FCS for
5 h before treatment to evaluate IL-10 activity (Western-blot and qPCR). Wild-type
and E230 mice24 were sacrificed using a CO2 chamber and immediately dissected
to isolate bone marrow cells by flushing the tibias and femurs with a 23G syringe
filled with cold complete culture medium containing 20% FCS. Cells were washed,
plated at a density of approximately 2 × 106 cells/ml and treated with 20 ng/ml M-
CSF for 6 days, with a medium change at day 3. Adherent cells were then harvested
using a cell scraper and plated in complete medium containing 20% FCS and
lacking M-CSF for 16 h. Cells were incubated the next day for 5 h in DMEM/1%
FCS before conducting different assays in response to IL-10 (Western-blot and
qPCR). Depending on the final cell yield, different number of experimental replicas
were used for each WT/E230 mouse pair.
Quantitative PCR. THP1 cells and BMDMs were washed and lysed in-plate using
the RNeasy Mini Kit (Qiagen) for RNA isolation. Quantitative PCR was carried out
using the qPCR iTaq Universal SYBR Green One-Step kit (BioRad) using 30–50 ng
of total RNA as a template. Oligonucleotides were selected using the PrimerBank
Primer Search on-line tool (MGH, Harvard; https://pga.mgh.harvard.edu/
primerbank/); sequences are shown in Supplementary Table 5. Data were collected
using the BioRad iQ5TM 2.0 Standard Edition Optical System Software, and later
corrected against the results obtained for housekeeping genes (Actin, GAPDH)
following the 2−ΔΔCT method39.
Animals and ethics. Mice were maintained in ventilated racks in a Specific
Pathogen-Free facility under controlled temperature (23 °C), humidity (50%) and
light/dark cycle (12 h/12 h) conditions, strictly following European Union regula-
tions. All procedures were evaluated and approved by the Ethics and Animal
Wellbeing Committees of the University of Salamanca and the Junta de Castilla y
Leon local government.
Statistics and reproducibility. Unless otherwise stated, all graphs represent
mean−/+ standard deviation values obtained from the indicated number of
experimental points (n). Graphs were generated using GraphPad Prism 7.04, except
those in Fig. 1b, c and Supplementary Fig. 1a that were created with Excel 1902.
Box-plots were used to represent the number of intracellular vesicles per cell and
the degree of colocalization with endocytic markers in those figures displaying
intracellular trafficking data obtained from engineered MEFs, since this plot type
displays more graphically the wide experimental dispersion that we found in these
assays. In the shown box-plots, the box indicates numerical data included in
percentiles 25–75, the central line represents the median value and the whiskers
include the most extreme values. Statistical significance was established in all cases
by calculating the P-values resulting from two-tailed Student’s t-tests. All experi-
ments were reproduced at least 3 times with similar results.
Fig. 6 Function of the WDD in IL-10 signaling in THP1 cells and BMDMs. a Pulse-chase assay of IL-10-induced STAT3 phosphorylation in differentiated
THP1 cells. The indicated strains (F: endogenous full-length ATG16L1; N: CRISPR/Cas9-induced ATG16L1 depletion (guide 1025–1044) plus restoration
with the Nt domain, aminoacids 1–299) were treated with PMA (125 ng/ml; 48 h), pre-incubated with IL-10 (50 ng/ml; 30min on ice), incubated at 37 °C
for the shown times and lysed to obtain nuclear extracts for the indicated Western-blots. Corrected densitometric quantifications are shown at the bottom
of the Western-blot images. b Quantitative PCR to assess IL-10-induced suppression of TNF and IL-6 mRNA upregulation by LPS in THP1 cells. Cells were
pre-activated as in a, treated with LPS (TNF, 10 ng/ml; IL-6, 10 or 60 ng/ml) for 5 h with or without IL-10 (50 ng/ml) and lysed for qPCR. Shown are
average fold inhibition values induced by IL-10 −/+ s.d. (TNF: n= 7, IL-6: n= 6 experimental points; *P < 0.05; **P < 0.01, two-sided Student’s t-test). c
Pulse-chase assay of IL-10-induced STAT3 phosphorylation in BMDMs. BMDMs from 3 randomly-chosen mouse pairs (F: full-length ATG16L1; N: E230
mice expressing the Nt domain) were pre-incubated with IL-10 (50 ng/ml; 30min on ice), incubated at 37 °C for the shown times and lysed to obtain
nuclear extracts for the indicated Western-blots. Corrected densitometric quantifications are shown at the bottom of the Western-blot images. A statistical
analysis of nuclear P-STAT3 signals is shown in Supplementary Fig. 16c. d Quantitative PCR to evaluate IL-10-induced expression of Bcl3. BMDMs from the
indicated mice were treated with IL-10 (50 ng/ml, 4 h) and lysed for qPCR. Shown are average fold induction values induced by IL-10 −/+ s.d. (n= 6 mice;
*P < 0.05, two-sided Student’s t-test). e Quantitative PCR to assess IL-10-induced suppression of TNF mRNA upregulation by LPS. BMDMs from the
indicated mice were treated with LPS (1 ng/ml; 6 h) with or without IL-10 (50 ng/ml) and lysed for qPCR. Shown are average fold inhibition values induced
by IL-10 −/+ s.d. (n= 5 mice; *P < 0.05, two-sided Student’s t-test).
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Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The database of human type-I transmembrane proteins used to search for the WDD-
binding motif is available as Supplementary Data 5. Information about how to retrieve
this database from the public Uniprot sequence bank is provided in the “Methods”
section (under Prosite Comparisons). All data are available in the article and
Supplementary files or from the corresponding author upon reasonable request. Source
data are provided with this paper.
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